159 related articles for article (PubMed ID: 27258375)
1. Speed of reversal of vecuronium neuromuscular block with different doses of neostigmine in anesthetized dogs.
Martin-Flores M; Lorenzutti AM; Litterio NJ; Rossetti VL; Zarazaga MP; Bonetto CC; Aguirre GE
Vet Anaesth Analg; 2017 Jan; 44(1):28-34. PubMed ID: 27258375
[TBL] [Abstract][Full Text] [Related]
2. Effects of neostigmine or edrophonium on force of contraction when administered at a train-of-four ratio of 0.9 in anesthetized dogs.
Romano M; Martin-Flores M; Sakai DM; Tseng CT; Campoy L; Gleed RD
Vet Anaesth Analg; 2017 Nov; 44(6):1313-1320. PubMed ID: 29066245
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of neostigmine antagonism at different levels of vecuronium-induced neuromuscular blockade in isoflurane anesthetized dogs.
Lorenzutti AM; Martin-Flores M; Baldivieso JM; Himelfarb MA; Litterio NJ
Can Vet J; 2014 Feb; 55(2):156-60. PubMed ID: 24489395
[TBL] [Abstract][Full Text] [Related]
4. Conditions to optimise the reversal action of neostigmine upon a vecuronium-induced neuromuscular block.
Baurain MJ; Dernovoi BS; D'Hollander AA; Hennart DA; Cantraine FR
Acta Anaesthesiol Scand; 1996 May; 40(5):574-8. PubMed ID: 8792887
[TBL] [Abstract][Full Text] [Related]
5. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
Mosing M; Auer U; West E; Jones RS; Hunter JM
Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
[TBL] [Abstract][Full Text] [Related]
6. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
[TBL] [Abstract][Full Text] [Related]
7. Recovery from neuromuscular block in dogs: restoration of spontaneous ventilation does not exclude residual blockade.
Martin-Flores M; Sakai DM; Campoy L; Gleed RD
Vet Anaesth Analg; 2014 May; 41(3):269-77. PubMed ID: 24754501
[TBL] [Abstract][Full Text] [Related]
8. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Bülow K
J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
[TBL] [Abstract][Full Text] [Related]
9. Failure to reverse prolonged vecuronium-induced neuromuscular blockade with edrophonium in an anesthetized dog.
Martin-Flores M; Boesch J; Campoy L; Gleed RD
J Am Anim Hosp Assoc; 2011; 47(4):294-8. PubMed ID: 21673340
[TBL] [Abstract][Full Text] [Related]
10. Observations of the potency and duration of vecuronium in isoflurane-anesthetized horses.
Martin-Flores M; Pare MD; Adams W; Campoy L; Gleed RD
Vet Anaesth Analg; 2012 Jul; 39(4):385-9. PubMed ID: 22642379
[TBL] [Abstract][Full Text] [Related]
11. [Effects of halothane and sevoflurane on reversal of neuromuscular blockade induced by vecuronium in man].
Izawa H; Takeda J; Fukushima K
Masui; 1997 Feb; 46(2):177-83. PubMed ID: 9071099
[TBL] [Abstract][Full Text] [Related]
12. Effects of residual concentrations of isoflurane on the reversal of vecuronium-induced neuromuscular blockade.
Baurain MJ; d'Hollander AA; Melot C; Dernovoi BS; Barvais L
Anesthesiology; 1991 Mar; 74(3):474-8. PubMed ID: 1672059
[TBL] [Abstract][Full Text] [Related]
13. Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium.
Caldwell JE
Anesth Analg; 1995 Jun; 80(6):1168-74. PubMed ID: 7762847
[TBL] [Abstract][Full Text] [Related]
14. Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: A randomised controlled trial.
Fuchs-Buder T; Baumann C; De Guis J; Guerci P; Meistelman C
Eur J Anaesthesiol; 2013 Oct; 30(10):594-8. PubMed ID: 23803594
[TBL] [Abstract][Full Text] [Related]
15. Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients.
Suzuki T; Masaki G; Ogawa S
Br J Anaesth; 2006 Aug; 97(2):160-3. PubMed ID: 16782976
[TBL] [Abstract][Full Text] [Related]
16. Reversal of Vecuronium-induced Neuromuscular Blockade with Low-dose Sugammadex at Train-of-four Count of Four: A Randomized Controlled Trial.
Asztalos L; Szabó-Maák Z; Gajdos A; Nemes R; Pongrácz A; Lengyel S; Fülesdi B; Tassonyi E
Anesthesiology; 2017 Sep; 127(3):441-449. PubMed ID: 28640017
[TBL] [Abstract][Full Text] [Related]
17. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
[TBL] [Abstract][Full Text] [Related]
18. Reversal of vecuronium with neostigmine: a comparison between male and female patients.
Saitoh Y; Aoki K; Okazaki M; Hirama T; Isosu T; Murakawa M
Fukushima J Med Sci; 2009 Dec; 55(2):61-70. PubMed ID: 20608096
[TBL] [Abstract][Full Text] [Related]
19. Neostigmine reversal of vecuronium neuromuscular block and the influence of renal failure.
Dhonneur G; Rebaine C; Slavov V; Ruggier R; De Chaubry V; Duvaldestin P
Anesth Analg; 1996 Jan; 82(1):134-8. PubMed ID: 8712389
[TBL] [Abstract][Full Text] [Related]
20. The influence of atropine dose on recovery from vecuronium-induced neuromuscular blockade.
Baurain MJ; Dernovoi BS; d'Hollander AA; Barvais L
Anesthesiology; 1992 Jul; 77(1):17-20. PubMed ID: 1351705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
